secwatch.observer — SEC 8-K summary
======================================

Issuer:     X4 Pharmaceuticals, Inc (XFOR)
CIK:        0001501697
Form:       8-K
Filed at:   2024-04-01T23:59:59+00:00
Accession:  0001628280-24-013896
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

X4 Pharmaceuticals posts updated corporate presentation on website
------------------------------------------------------------------

- X4 Pharmaceuticals filed an 8-K on April 1, 2024, announcing an updated corporate presentation.
- The presentation is available on the Investors section of the company's website at www.x4pharma.com.
- No financial results, material agreements, or other major events were disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501697/000162828024013896/0001628280-24-013896-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501697/000162828024013896/xfor-20240401.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-013896

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer